Stocknear Logo Stocknear
ctrl K
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
  • Login
    Stocknear Logo Stocknear
    Start new chat
    Home
    Hedge Funds
    News
    Pricing Plan

    ChromaDex Corporation (CDXC)

    NASDAQ: CDXC · Real-Time Price · USD
    7.87
    -0.07 (-0.88%)
    At close: Mar 18, 2025, 3:59 PM
      Overview Financials Statistics Metrics Forecast Dark Pool Options Insider Dividends History Profile
      Insider Trading 13F Institute Transcripts

    Transcripts

    Pro Subscription

    Upgrade now for unlimited access to all data, tools and no ads.

    CDXC News

    • 80 days ago - ChromaDex Evolves Into Niagen Bioscience, Marking a New Era of Uncovering the Potential of NAD+ With Precision Science - businesswire.com
    • 86 days ago - ChromaDex Corp. Announces Name Change to Niagen Bioscience, Inc. and New Ticker Symbol "NAGE" Effective March 19, 2025 - businesswire.com
    • 87 days ago - ChromaDex to Present at the 37th Annual Roth Conference - businesswire.com
    • 93 days ago - ChromaDex Capitalizes On Longevity Boom But Valuation Remains High - seekingalpha.com
    • 94 days ago - ChromaDex Corporation (CDXC) Q4 2024 Earnings Call Transcript - seekingalpha.com
    • 94 days ago - ChromaDex (CDXC) Q4 Earnings and Revenues Surpass Estimates - zacks.com
    • 94 days ago - ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2024 Results - businesswire.com
    • 107 days ago - Pick These 4 Stocks With Solid Net Profit Margin to Boost Return - zacks.com

    Add to Watchlist

    Sections

    • Stocks
    • IPOs
    • ETFs
    • Blog

    Services

    • Pricing Plan
    • Discord Bot
    • Free Newsletter
    • Get Support

    Website

    • Login
    • FAQ
    • Sitemap
    • Learning Center
    • Affiliate Program

    Company

    • About
    • Contact Us
    • Terms of Use
    • Privacy Policy
    • Data Disclaimer
    • Imprint

    © 2025 Stocknear. All rights reserved.